gamma-aminobutyric acid has been researched along with Optic Nerve Diseases in 1 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Optic Nerve Diseases: Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crofts, K | 1 |
Brennan, R | 1 |
Kearney, P | 1 |
O'Connor, G | 1 |
1 other study available for gamma-aminobutyric acid and Optic Nerve Diseases
Article | Year |
---|---|
Vigabatrin-induced optic neuropathy.
Topics: Anticonvulsants; Child; Female; gamma-Aminobutyric Acid; Humans; Optic Nerve Diseases; Vigabatrin | 1997 |